SHARPIN通过Rap1信号通路促进黑色素瘤进展
该研究探讨SHARPIN在黑色素瘤转移中的功能及分子机制。发现SHARPIN在黑色素瘤组织中表达升高,并在体内外激活增殖、迁移和侵袭过程,导致预后不良。功能分析表明SHARPIN通过调控Rap1及其下游p38和JNK/c-Jun通路促进黑色素瘤迁移和侵袭。
要点
- SHARPIN在黑色素瘤组织中表达升高,与不良预后相关
- SHARPIN通过上调Rap1激活p38和JNK/c-Jun通路促进迁移侵袭
- Rap1激活剂和抑制剂可部分逆转SHARPIN对肿瘤细胞侵袭迁移的作用
核心结论
- SHARPIN通过上调Rap1表达,经p38和JNK/c-Jun通路促进黑色素瘤发展。
研究设计与样本
- 研究采用黑色素瘤组织、细胞系及公共数据集,进行体内外功能实验和分子机制分析。
主要发现
- SHARPIN在黑色素瘤组织中表达增加,并在体内外激活增殖、迁移和侵袭过程,导致预后不良。
- SHARPIN通过调控Rap1及其下游p38和JNK/c-Jun通路促进黑色素瘤迁移和侵袭。
- Rap1激活剂(8-pCPT-2'-O-Me-cAMP)和抑制剂(ESI-09和farnesylthiosalicylic acid-amide)处理可部分挽救肿瘤细胞的侵袭和迁移。
- 细胞系和公共数据集显示BRAF和N-RAS以外的分子可能贡献于SHARPIN激活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SHARPIN, as a tumor-associated gene, is involved in the metastatic process of many kinds of tumors. Herein, we studied the function of Shank-associated RH domain interacting protein (SHARPIN) in melanoma metastasis and the relevant molecular mechanisms. We found that SHARPIN expression was increased in melanoma tissues and activated the process of proliferation, migration, and invasion in vitro and in vivo, resulting in a poor prognosis of the disease. Functional analysis demonstrated that SHARPIN promoted melanoma migration and invasion by regulating Ras-associated protein-1(Rap1) and its downstream pathways, including p38 and JNK/c-Jun. Rap1 activator (8-pCPT-2'-O-Me-cAMP) and inhibitor (ESI-09 and farnesylthiosalicylic acid-amide) treatments could partially rescue invasion and migration of tumor cells. Additionally, SHARPIN expression in cell lines and public datasets also indicated that molecules other than BRAF and N-RAS may contribute to SHARPIN activation. In conclusion, our broad-in-depth work suggests that SHARPIN promotes melanoma development via p38 and JNK/c-Jun pathways through upregulation of Rap1 expression.
引用
- Zhou S, Liang Y, Zhang X, et al. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway. J Invest Dermatol. 2019. PMID: 31401046. doi:10.1016/j.jid.2019.07.696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。